SUTRO BIOPHARMA, INC.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $173.8M
Liabilities Breakdown FY2025
Total Liabilities: $306.3M
Asset Breakdown
Total Assets: $173.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $58.1M | 33.4% |
| Accounts Receivable | $4.0M | 2.3% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $10.6M | 6.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $101.1M | 58.1% |
Liabilities Breakdown
Total Liabilities: $306.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $7.6M | 2.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $298.7M | 97.5% |